相似文献
1
GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
Br J Pharmacol. 1992 Sep;107(1):141-5. doi: 10.1111/j.1476-5381.1992.tb14476.x.
2
Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Biochem Pharmacol. 1993 Jan 26;45(2):375-83. doi: 10.1016/0006-2952(93)90073-6.
3
Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Mol Pharmacol. 1988 Feb;33(2):178-86.
4
5
Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
J Neurochem. 1991 Apr;56(4):1276-85. doi: 10.1111/j.1471-4159.1991.tb11422.x.
6
Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Brain Res. 1999 Jan 16;816(1):165-74. doi: 10.1016/s0006-8993(98)01156-1.
7
Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Oct;346(4):367-74. doi: 10.1007/BF00171076.
8
5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
J Pharmacol Exp Ther. 2000 Feb;292(2):684-91.
9
Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Jun;359(6):454-9. doi: 10.1007/pl00005375.
10
Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Eur J Pharmacol. 1998 Apr 17;347(1):41-9. doi: 10.1016/s0014-2999(98)00085-5.
本文引用的文献
1
Some quantitative uses of drug antagonists.
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
2
The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells.
Mol Pharmacol. 1981 Jan;19(1):38-43.
3
Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Endocrinology. 1983 Nov;113(5):1541-50. doi: 10.1210/endo-113-5-1541.
4
Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Br J Pharmacol. 1988 Nov;95(3):975-85. doi: 10.1111/j.1476-5381.1988.tb11728.x.
5
NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Eur J Pharmacol. 1988 Sep 23;154(3):339-41. doi: 10.1016/0014-2999(88)90212-9.
6
5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus.
Eur J Pharmacol. 1988 Sep 1;154(1):95-8. doi: 10.1016/0014-2999(88)90369-x.
7
Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Biochem Pharmacol. 1988 Sep 15;37(18):3429-33. doi: 10.1016/0006-2952(88)90692-2.
8
Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
J Pharmacol Exp Ther. 1986 Jul;238(1):248-53.
9
Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Mol Pharmacol. 1988 Feb;33(2):178-86.
10
5-Hydroxytryptamine receptor "families".
FASEB J. 1989 Sep;3(11):2242-9. doi: 10.1096/fasebj.3.11.2673898.
Zotero 插件